Reference health

Isoacteoside, a dihydroxyphenylethyl glycoside, exhibits anti‐inflammatory effects through blocking toll‐like receptor 4 dimerization

https://doi.org/10.1111/bph.13912
CiteStamped reference-health badge
51/51 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 51 checked references that resolve
resolves10.1136/bmj.39139.716794.55
Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis
resolves10.1016/j.it.2013.03.007
Cell type-specific function of TAK1 in innate immune signaling
resolves10.1111/bph.13353
The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors
resolves10.1111/bph.13354
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
resolves10.1038/nrmicro2266
The molecular basis of the host response to lipopolysaccharide
resolves10.1038/35065000
Mammalian MAP kinase signalling cascades
resolves10.1002/mnfr.201400819
Resveratrol attenuates lipopolysaccharide‐induced acute kidney injury by suppressing inflammation driven by macrophages
resolves10.1111/bph.13040
<scp>WMJ</scp>‐<scp>S</scp>‐001, a novel aliphatic hydroxamate derivative, exhibits anti‐inflammatory properties via <scp>MKP</scp>‐1 in <scp>LPS</scp>‐stimulated <scp>RAW</scp>264.7 macrophages
resolves10.1002/eji.1830260611
Selective inhibition of interleukin‐1β gene expression in activated RAW 264.7 macrophages by interferon‐γ
resolves10.33549/physiolres.931936
New developments in septic acute kidney injury
resolves10.1590/S1516-31802007000400009
Early dexamethasone treatment for septic shock patients: a prospective randomized clinical trial
resolves10.1038/nature01326
The immunopathogenesis of sepsis
resolves10.1111/bph.12856
Experimental design and analysis and their reporting: new guidance for publication in <scp>BJP</scp>
resolves10.1074/jbc.M115.649087
Activation of Human Toll-like Receptor 4 (TLR4)·Myeloid Differentiation Factor 2 (MD-2) by Hypoacylated Lipopolysaccharide from a Clinical Isolate of Burkholderia cenocepacia
resolves10.1172/JCI24792
Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF- B decoy oligonucleotides
resolves10.1038/srep33720
Tanshinones and diethyl blechnics with anti-inflammatory and anti-cancer activities from Salvia miltiorrhiza Bunge (Danshen)
resolves10.1142/S0192415X1550072X
Total Tanshinones-Induced Apoptosis and Autophagy <i>Via</i> Reactive Oxygen Species in Lung Cancer 95D Cells
resolves10.1155/2014/354843
NF-<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mrow><mml:mi>κ</mml:mi></mml:mrow></mml:math>B/AP-1-Targeted Inhibition of Macrophage-Mediated Inflammatory Responses by Depigmenting Compound AP736 Derived from Natural 1,3-Diphenylpropane Skeleton
resolves10.1038/nrd3203
Targeting Toll-like receptors: emerging therapeutics?
resolves10.1155/2015/608126
AP-1-Targeting Anti-Inflammatory Activity of the Methanolic Extract of<i>Persicaria chinensis</i>
resolves10.4049/jimmunol.166.9.5688
Endotoxin-Induced Maturation of MyD88-Deficient Dendritic Cells
resolves10.1016/j.bbapap.2005.08.017
MAPK signalling pathways as molecular targets for anti-inflammatory therapy—from molecular mechanisms to therapeutic benefits
resolves10.1111/j.1476-5381.2010.00872.x
Animal research: Reporting <i>in vivo</i> experiments: The ARRIVE guidelines
resolves10.1007/s12272-009-1112-6
Anti-inflammatory phenylpropanoid glycosides from Clerodendron trichotomum leaves
resolves10.3390/ijms17111938
Anti-Inflammatory Effects of Chloranthalactone B in LPS-Stimulated RAW264.7 Cells
resolves10.1038/sj.bjp.0704404
Nuclear factor kappa B is involved in lipopolysaccharide‐stimulated induction of interferon regulatory factor‐1 and GAS/GAF DNA‐binding in human umbilical vein endothelial cells
resolves10.1016/j.jep.2013.06.042
Antimicrobial, anti-inflammatory activities and toxicology of phenylethanoid glycosides from Monochasma savatieri Franch. ex Maxim
resolves10.1038/sj.bjp.0707187
YC‐1 attenuates LPS‐induced proinflammatory responses and activation of nuclear factor‐κB in microglia
resolves10.3390/ijms141223980
Anti-Inflammatory Effects of 4-Methylcyclopentadecanone on Edema Models in Mice
resolves10.1111/bph.12955
Implementing guidelines on reporting research using animals (<scp>ARRIVE</scp> etc.): new requirements for publication in <scp>BJP</scp>
resolves10.1038/41131
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
resolves10.1016/j.vetimm.2006.04.002
In vitro down regulation of proinflammatory cytokines induced by LPS tolerance in pig CD14+ cells
resolves10.1152/ajplung.2000.278.6.L1289
Brief hypoxia differentially regulates LPS-induced IL-1β and TNF-α gene transcription in RAW 264.7 cells
resolves10.1038/nature07830
The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
resolves10.1038/srep23240
Micheliolide inhibits LPS-induced inflammatory response and protects mice from LPS challenge
resolves10.1097/ACO.0b013e3282f4db7a
Early goal-directed therapy in severe sepsis and septic shock: a contemporary review of the literature
resolves10.1046/j.1365-2249.2000.01373.x
Differential anti-inflammatory and anti-oxidative effects of dexamethasone and N-acetylcysteine in endotoxin-induced lung inflammation
resolves10.1093/intimm/dxh097
Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization
resolves10.1111/j.1476-5381.2011.01670.x
Potent anti‐inflammatory effect of a novel furan‐2,5‐dione derivative, BPD, mediated by dual suppression of COX‐2 activity and LPS‐induced inflammatory gene expression via NF‐κB inactivation
resolves10.1093/nar/gkv1037
The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
resolves10.1016/S0027-5107(01)00183-X
Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation
resolves10.1371/journal.pone.0030134
Amelioration of Acute Kidney Injury in Lipopolysaccharide-Induced Systemic Inflammatory Response Syndrome by an Aldose Reductase Inhibitor, Fidarestat
resolves10.1124/jpet.105.097584
A Selective Small Molecule IκB Kinase β Inhibitor Blocks Nuclear Factor κB-Mediated Inflammatory Responses in Human Fibroblast-Like Synoviocytes, Chondrocytes, and Mast Cells
resolves10.1038/sj.bjp.0704803
Inhibition of LPS‐stimulated pathways in macrophages by the flavonoid luteolin
resolves10.1038/srep27583
Abrogating ClC-3 Inhibits LPS-induced Inflammation via Blocking the TLR4/NF-κB Pathway
resolves10.1007/s10753-014-9816-2
Punicalagin Inhibits Inflammation in LPS-Induced RAW264.7 Macrophages via the Suppression of TLR4-Mediated MAPKs and NF-κB Activation
resolves10.1074/jbc.M802825200
Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop Is Required for Interleukin (IL)-1-mediated Optimal NFκB and AP-1 Activation as Well as IL-6 Gene Expression
resolves10.1681/ASN.2010050484
Sepsis and Acute Kidney Injury
resolves10.1038/srep14715
Natural small molecule FMHM inhibits lipopolysaccharide-induced inflammatory response by promoting TRAF6 degradation via K48-linked polyubiquitination
resolves10.4049/jimmunol.170.12.6307
An Inducible Nitric Oxide Synthase-Luciferase Reporter System for In Vivo Testing of Anti-inflammatory Compounds in Transgenic Mice
The 3 references without a DOI — listed, not checked
no DOI — not checkedp38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases
no DOI — not checkedTranscriptional repression by shikonin involves inactivation of TATA box‐binding protein in vivo
no DOI — not checkedBone marrow‐derived macrophage production
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1111/bph.13912"><img src="https://citestamp.com/citestamped/10.1111/bph.13912/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1111/bph.13912/badge.svg)](https://citestamp.com/citestamped/10.1111/bph.13912)